Stockreport

Forget ImmunityBio: This Big-Cap Pharma Is the Safer Play on Next-Gen Cancer Therapies [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF Oncology is the largest therapeutic area in the biopharma industry, in terms of sales. The rapid rise in recent years of drugs to treat diabetes and manage weight loss [Read more]